| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $9.77M | $9.45M | $15.49M | $9.00M | $8.41M |
| SG&A | $10.16M | $6.20M | $7.27M | $8.51M | $12.27M |
| Operating Income | -$19.94M | -$15.64M | -$22.76M | -$17.50M | -$20.68M |
| Interest Expense | $901.33K | $25.35K | $790.00K | $292.34K | $33.41K |
| Tax Expense | – | – | – | – | – |
| Net Income | -$22.45M | -$15.55M | -$23.53M | -$17.68M | -$20.71M |
| EPS (basic) | -4.4400 | -10.2000 | -26.0000 | -1.5600 | -2.7900 |
| EPS (diluted) | -4.4400 | -10.2000 | -26.0000 | -29.3500 | – |
| Shares (diluted) | $5.06M | $1.52M | $905.23K | $602.34K | – |